<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02358525</url>
  </required_header>
  <id_info>
    <org_study_id>J3256</org_study_id>
    <nct_id>NCT02358525</nct_id>
  </id_info>
  <brief_title>Effects of a Rehabilitation Program on Immune Activation and Mood in Heart Failure Patients</brief_title>
  <official_title>Effects of a Multi-Modality Rehabilitation Program on Immune Activation, Depressive Symptoms and Quality of Life in Heart Failure Patients. A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this descriptive study is to examine potential changes regarding inflammatory
      cytokine levels, depressive symptoms and quality of life over the course of the 4-week
      inpatient rehabilitation program which includes a cassette of modalities including
      counseling, psychosocial education and supervised exercise training as a main pillar, and to
      further investigate if there are correlations between changes in immune regulation,
      depressive symptoms and quality of life.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>inflammatory activity</measure>
    <time_frame>8 weeks</time_frame>
    <description>levels of inflammatory biomarkers: Interleukin - 6, Tumor Necrosis Factor-alpha, Interleukin-1beta, Cellular Adhesion Molecule-1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>physical fitness</measure>
    <time_frame>8 weeks</time_frame>
    <description>6-min-walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>8 weeks</time_frame>
    <description>questionnaires: SF-36 (short-form-36), KCCQ (Kansas City Cardiomyopathy Questionnaire), EQoL-5D (European Quality of LIfe-5Dimensions)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depressive Symptoms</measure>
    <time_frame>8 weeks</time_frame>
    <description>questionnaire: HADS (Hospital Anxiety and Depression Scale)</description>
  </secondary_outcome>
  <enrollment type="Actual">16</enrollment>
  <condition>Heart Failure</condition>
  <condition>Depressive Symptoms</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>multi-modality rehabilitation program for heart failure</intervention_name>
    <description>rehabilitation consists of supervised exercise training, both endurance and strength, as well as gymnastics, diet and psychosocial education around living with heart failure</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Heart failure patients, EF ≤ 45%, NYHA I - III; ACC/AHA stage C
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of heart failure with reduced ejection fraction (HFREF) with an EF ≤ 45%,
             NYHA (New York Heart Association) I - III; ACC/AHA (American College of Cariology/
             American Heart Association) stage C, irrespective of etiology

          -  Clinically stable patients without deterioration or hospitalization due to heart
             failure within the last 4 weeks

          -  Neuro-hormonal medication according to the ESC (European Society of Cardiology)
             guidelines for the treatment of chronic heart failure consisting of antagonists of the
             Renin-Angiotensin-Aldosterone System (RAAS) and beta-blockers as indicated.

          -  Ability to fully understand all elements of and sign the written informed consent
             before initiation of the study

        Exclusion Criteria:

          -  Fluid retention of cardiac decompensation, necessitating i.v. diuretic therapy

          -  Myocardial infarction within the last 2 months

          -  Surgery including cardiovascular or valvular surgery within 3 Months

          -  Uncontrolled proinflammatory comorbidities (e.g. Diabetes mellitus HbA1c &gt;9%, COPD (
             chronic obstructive pulmonary disease) &gt;II, active rheumatic diseases and autoimmune
             disorders)

          -  Current infectious diseases ( e.g. pneumonia, COPD exacerbations or urinary tract
             infections)

          -  Morbid obesity: BMI &gt; 40

          -  Alcohol or drug abuse

          -  psychiatric disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>katherine wachmann, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ludwig Boltzmann IRBR</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ska Rz Grossgmain</name>
      <address>
        <city>Grossgmain</city>
        <state>Salzburg</state>
        <zip>5084</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SALK, 2.Medizin, HI-Ambulanz</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>February 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 9, 2015</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Boltzmann Institut fuer Rheumatologie, Balneologie und Rehabilitation</investigator_affiliation>
    <investigator_full_name>Dr. Katherine Wachmann</investigator_full_name>
    <investigator_title>Study coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

